scholarly article | Q13442814 |
P819 | ADS bibcode | 1991PNAS...88.6167C |
P356 | DOI | 10.1073/PNAS.88.14.6167 |
P932 | PMC publication ID | 52043 |
P698 | PubMed publication ID | 2068098 |
P5875 | ResearchGate publication ID | 21088128 |
P50 | author | Jonathan D. Katz | Q57140999 |
Serge M Candéias | Q57770309 | ||
P2093 | author name string | C Benoist | |
K Haskins | |||
D Mathis | |||
P2860 | cites work | Pancreatic islet-specific T-cell clones from nonobese diabetic mice | Q34313103 |
The structure of V alpha and J alpha segments in the mouse | Q36077529 | ||
The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides | Q36351944 | ||
T cell receptor variable gene usage in a specific cytotoxic T cell response. Primary structure of the antigen-MHC receptor of four hapten-specific cytotoxic T cell clones | Q36352443 | ||
Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus | Q36796002 | ||
Molecular analysis of antigen recognition by insulin-specific T-cell hybridomas from B6 wild-type and bm12 mutant mice | Q36840517 | ||
The T lymphocyte in experimental allergic encephalomyelitis | Q37925549 | ||
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. | Q37925551 | ||
The T-cell receptor repertoire and autoimmune diseases | Q38201553 | ||
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy | Q39272381 | ||
Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families | Q39485419 | ||
Identification and characterization of new murine T cell receptor beta chain variable region (V beta) genes | Q41814249 | ||
Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides | Q43794379 | ||
Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone | Q44534362 | ||
Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis | Q45351794 | ||
Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells | Q45852082 | ||
Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients | Q46081307 | ||
T-lymphocyte clone specific for pancreatic islet antigen | Q46335815 | ||
Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention | Q46499427 | ||
The T cell receptor V alpha 3 gene segment is associated with reactivity to p-azobenzenearsonate | Q48319186 | ||
Receptor diversity of insulin-specific T cell lines from C57BL (H-2b) mice. | Q48344016 | ||
Correlations between T-cell specificity and the structure of the antigen receptor | Q48365072 | ||
Dominance of one T-cell receptor in the H–2Kb/TNP response | Q58968930 | ||
An explanation for the protective effect of the MHC class II I–E molecule in murine diabetes | Q59081580 | ||
MHC-linked protection from diabetes dissociated from clonal deletion of T cells | Q68344478 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6167-6170 | |
P577 | publication date | 1991-07-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors | |
P478 | volume | 88 |
Q70722241 | A comparative study of T-cell receptor V beta usage in non-obese diabetic (NOD) and I-E transgenic NOD mice |
Q30311456 | A protective NOD islet-infiltrating CD8+ T cell clone, I.S. 2.15, has in vitro immunosuppressive properties |
Q56880557 | Analysis of the Peripheral T-Cell Receptor VP Repertoire in Newly Diagnosed Patients with Type I Diabetes |
Q34517586 | Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage |
Q36365696 | CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice |
Q40787110 | Cellular basis of T-cell autoreactivity in autoimmune diseases |
Q41859484 | Characterization of the T cell receptor repertoire causing collagen arthritis in mice |
Q36365722 | Dual T cell receptor alpha chain T cells in autoimmunity |
Q72788288 | Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice |
Q63952511 | Efficient immune responses in mice lacking N-region diversity |
Q33715004 | Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile. |
Q36231586 | Evaluation of the functional equivalence of major histocompatibility complex class II A and E complexes |
Q52882904 | Evidence for a preferential V beta usage by the T cells which adoptively transfer diabetes in NOD mice. |
Q59060541 | Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope |
Q52025010 | High density insulin receptor-positive diabetogenic T lymphocytes in nonobese diabetic mice are memory cells. |
Q35022826 | High-throughput sequencing of islet-infiltrating memory CD4+ T cells reveals a similar pattern of TCR Vβ usage in prediabetic and diabetic NOD mice |
Q46408296 | High-throughput sequencing reveals restricted TCR Vβ usage and public TCRβ clonotypes among pancreatic lymph node memory CD4(+) T cells and their involvement in autoimmune diabetes |
Q37114342 | Hydrophobic CDR3 residues promote the development of self-reactive T cells |
Q43147458 | Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients |
Q36367689 | Immunization with soluble BDC 2.5 T cell receptor-immunoglobulin chimeric protein:antibody specificity and protection of nonobese diabetic mice against adoptive transfer of diabetes by maternal immunization |
Q50896247 | Individuals from multiplex insulin-dependent diabetes mellitus (IDDM) families express higher levels of TCRBV2S1 than controls. |
Q52207566 | Induction of diabetes with islet-specific T-cell clones is age dependent. |
Q72035895 | Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor V beta regions depending on the stage of the disease |
Q36377306 | Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition |
Q36400215 | Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities |
Q38691482 | Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation |
Q38660197 | Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation |
Q38611317 | Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells? |
Q44958053 | Monoclonal T cells identified in early NOD islet infiltrates |
Q42651261 | N-terminal flanking residues of a diabetes-associated GAD65 determinant are necessary for activation of antigen-specific T cells in diabetes-resistant mice |
Q35646174 | Non-obese diabetic transgenic mouse |
Q39264408 | Nuclear transferred embryonic stem cells for analysis of B1 B-lymphocyte development |
Q71838378 | Organ-specific disease provoked by systemic autoimmunity |
Q33221766 | Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse |
Q40066064 | Predominant use of a T-cell receptor V beta gene family in simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in a rhesus monkey |
Q35602903 | Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes |
Q37305242 | Regulation of N-region diversity in antigen receptors through thymocyte differentiation and thymus ontogeny |
Q36970573 | Regulation of autoimmunity |
Q34035323 | Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice |
Q42611081 | Shared structural motifs in TCR of glycopeptide-recognizing T cell hybridomas |
Q41534929 | Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line |
Q35919777 | Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity |
Q36870393 | T Cell Receptor Gene Polymorphisms Associated with Anti-Insulin, Autoimmune T Cells in Diabetes-Prone NOD Mice |
Q37174434 | T cell populations in the pancreatic lymph node naturally and consistently expand and contract in NOD mice as disease progresses |
Q33805895 | T cell receptor gene usage in autoimmune diabetes |
Q36049067 | T cell receptor restriction of diabetogenic autoimmune NOD T cells |
Q83205902 | T cells to a dominant epitope of GAD65 express a public CDR3 motif |
Q40465758 | T-cell receptor use in organ-specific human autoimmune diseases other than rheumatoid arthritis and multiple sclerosis. Summary and overview. |
Q35654189 | T-lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes mellitus |
Q40878852 | The immunologic insult in type 1 diabetes |
Q52225294 | The level of N-region diversity in T cell receptors is not pre-ordained in the stem cell. |
Q36375353 | The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope |
Q40433231 | Tolerance Induction as a Therapeutic Strategy for the Control of Autoimmune Endocrine Disease in Mouse Models |
Search more.